Gitnux/Report 2026

Preeclampsia Statistics

Preeclampsia is more than a pregnancy complication with sharp numbers that keep changing as better screening reshapes how often it is caught. See which figures in 2025 and 2026 reflect that shift, and what they mean for risk, timing, and outcomes when preeclampsia develops late or suddenly.
127Statistics
5Sections
6mRead
8 days agoUpdated
Preeclampsia Statistics
Verified via a 4-step process
01Source

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02Verify

Each statistic is independently verified via reproduction analysis and cross-referencing against independent databases.

03Grade

Figures are graded by cross-model consensus. Statistics failing independent corroboration are excluded regardless of how widely cited.

04Cite

Every figure carries a primary source. We maintain stable URLs and versioned verification dates so the report can be cited.

Read our full methodology →

Statistics that fail independent corroboration are excluded.

Next review Dec 2026
Preeclampsia complicates 2% to 8% of pregnancies worldwide, with severe disease present in 0.5% to 1% of cases. Each year, about 14% of maternal deaths globally are linked to preeclampsia, making this diagnosis a major driver of maternal risk. The clinical picture often starts with new-onset hypertension after 20 weeks plus proteinuria, so delayed detection can shift cases toward outcomes like stroke, stillbirth, and preterm birth.

Key Takeaways

  • Preeclampsia symptoms include new-onset hypertension after 20 weeks with proteinuria ≥300mg/24h.
  • Preeclampsia affects 2-8% of pregnancies globally, with higher rates in developing countries.
  • Magnesium sulfate prevents 50% of eclampsia seizures.
  • Preeclampsia increases maternal stroke risk 5-fold long-term.
  • Maternal age >35 years increases risk by 1.5-2 fold.

Preeclampsia affects millions worldwide, making early recognition and prenatal care crucial for safer pregnancies.

01 · Category

Clinical Features24 stats

01
Preeclampsia symptoms include new-onset hypertension after 20 weeks with proteinuria ≥300mg/24h.
02
Severe features: systolic BP ≥160 mmHg or diastolic ≥110 mmHg on two occasions.
03
Proteinuria defined as ≥300 mg per 24-hour urine collection or protein/creatinine ratio ≥0.3.
04
HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) in 10-20% of severe cases.
05
Headache persisting despite analgesics is a severe feature.
06
Visual disturbances like scotoma occur in 25% of severe preeclampsia.
07
Epigastric or right upper quadrant pain in 40-50% of severe cases.
08
Pulmonary edema present in 2-3% of preeclampsia cases.
09
Thrombocytopenia <100,000/μL indicates severity.
10
Elevated creatinine >1.1 mg/dL or doubling baseline is severe.
11
Liver enzymes >2x upper limit in 20% severe preeclampsia.
12
Fetal growth restriction in 25-30% of preeclampsia pregnancies.
13
Oligohydramnios seen in 15-20% cases.
14
Placental abruption risk 10 times higher.
15
Diagnosis without proteinuria if new thrombocytopenia, renal insufficiency, etc.
16
Edema in 80% but not diagnostic.
17
Hyperreflexia with clonus in severe disease.
18
Retinal changes like arteriolar narrowing on fundoscopy.
19
Urine dipstick ≥2+ protein correlates with ≥300mg/24h in 90%.
20
Mean arterial pressure >140 mmHg prompts evaluation.
21
Uric acid >5.5 mg/dL supports diagnosis.
22
sFlt-1/PlGF ratio >38 indicates high risk.
23
Ultrasound Doppler: absent end-diastolic flow in 15%.
24
Eclampsia seizures in 1-2% of preeclampsia cases.
Interpretation

Clinical Features Interpretation

Think of preeclampsia less as a single condition and more as your body's chaotic and dangerously overzealous attempt to draft a multi-system eviction notice for the pregnancy.

02 · Category

Epidemiology30 stats

01
Preeclampsia affects 2-8% of pregnancies globally, with higher rates in developing countries.
02
In the United States, about 4% of pregnancies are affected by preeclampsia each year.
03
Incidence of preeclampsia in first pregnancies is approximately 3.4%.
04
Severe preeclampsia occurs in 0.5-1% of all pregnancies worldwide.
05
Preeclampsia accounts for 14% of maternal deaths globally.
06
In low-income countries, preeclampsia/eclampsia causes 10-15% of maternal mortality.
07
Prevalence of preeclampsia in twin pregnancies is 10-20%.
08
Nulliparous women have a 5-6% risk of developing preeclampsia.
09
Preeclampsia recurs in 20-40% of subsequent pregnancies.
10
Early-onset preeclampsia (<34 weeks) occurs in 0.38% of pregnancies.
11
Late-onset preeclampsia (≥34 weeks) affects 2.31% of pregnancies.
12
Global burden: 10 million women affected by preeclampsia annually.
13
In Africa, preeclampsia incidence is up to 10%.
14
Hispanic women in the US have a 5.5% preeclampsia rate.
15
Non-Hispanic black women have 1.5 times higher preeclampsia risk than whites.
16
Age >40 years increases preeclampsia risk to 10-15%.
17
Preeclampsia superimposed on chronic hypertension affects 25-40%.
18
IVF pregnancies have 1.5-2 times higher preeclampsia incidence.
19
In Australia, preeclampsia affects 1 in 50 pregnancies.
20
UK preeclampsia prevalence is 5.6%.
21
Brazil reports 8-10% preeclampsia rate in public health system.
22
India has preeclampsia incidence of 8-10%.
23
China preeclampsia rate is 4.1%.
24
Canada reports 3.7% preeclampsia prevalence.
25
Europe average preeclampsia incidence 2-5%.
26
Preeclampsia in adolescents <20 years: 4.8%.
27
Women 35-39 years: 7.2% preeclampsia risk.
28
≥40 years: 11.1% preeclampsia incidence.
29
First birth after 30 years doubles preeclampsia risk.
30
Preeclampsia/eclampsia responsible for 50,000 maternal deaths yearly worldwide.
Interpretation

Epidemiology Interpretation

While the global threat of preeclampsia hides in a sobering 2-8% statistic, its cruel paradox is that it is both a common complication and a leading killer, disproportionately targeting first-time mothers, women of color, and those in developing nations with healthcare gaps.

03 · Category

Management22 stats

01
Magnesium sulfate prevents 50% of eclampsia seizures.
02
Delivery is definitive treatment after 34 weeks.
03
Expectant management <34 weeks if stable: prolongs pregnancy by 1-2 weeks.
04
Antihypertensives: labetalol, nifedipine, hydralazine for BP ≥160/110.
05
Low-dose aspirin 81-150mg from 12 weeks reduces risk by 10-24% in high-risk.
06
Calcium supplementation 1-2g/day reduces risk 35% in low-intake populations.
07
Bed rest not recommended; ambulatory management preferred.
08
Fetal monitoring: NST twice weekly <32 weeks.
09
Biophysical profile weekly after 32 weeks.
10
Corticosteroids for lung maturity if delivery <34 weeks.
11
Magnesium loading dose 4-6g IV, maintenance 1-2g/h.
12
Postpartum BP monitoring for 72 hours.
13
Preeclampsia resolves within 48 hours postpartum in 90%.
14
ACOG recommends screening high-risk with uterine artery Doppler.
15
Remote monitoring of BP reduces hospitalizations by 20%.
16
Lifestyle: weight loss pre-pregnancy reduces risk 20%.
17
No role for diuretics routinely.
18
Timing of delivery: 37 weeks for mild preeclampsia.
19
Cesarean if unstable or <34 weeks with severe features.
20
Prophylactic antibiotics for cesarean reduce endometritis.
21
Postpartum thromboprophylaxis if indicated.
22
Long-term CV risk: 2-4 fold increase post-preeclampsia.
Interpretation

Management Interpretation

In the high-stakes chess match of preeclampsia, we hold the line with magnesium and aspirin while the clock ticks, knowing that the ultimate move is timely delivery, after which we watch the board carefully for years because the game has a way of continuing long after the pieces are put away.

04 · Category

Outcomes26 stats

01
Preeclampsia increases maternal stroke risk 5-fold long-term.
02
Perinatal mortality 5-10 times higher with preeclampsia.
03
Preterm birth <37 weeks in 25-50% of cases.
04
Intrauterine growth restriction (IUGR) in 28%.
05
Stillbirth risk 4-fold increased.
06
Neonatal ICU admission 3 times higher.
07
Maternal mortality 0.4% in severe preeclampsia.
08
Eclampsia mortality 1-2%.
09
HELLP syndrome mortality 1-2%.
10
Placental abruption in 5-10% severe cases.
11
Pulmonary edema mortality up to 5%.
12
Cerebral hemorrhage in eclampsia: 25% of fatalities.
13
Offspring CV disease risk 2-fold later in life.
14
Maternal diabetes risk doubles post-preeclampsia.
15
Chronic hypertension develops in 15-50% within years.
16
Renal failure risk 10 times higher long-term.
17
Early-onset preeclampsia: 20% perinatal mortality.
18
Late-onset: <5% perinatal mortality.
19
Recurrent preeclampsia: worse outcomes in 30%.
20
In developing countries, case fatality 5-15%.
21
US maternal mortality from preeclampsia: 70 per 100,000 cases.
22
Fetal death rate 1.3% in preeclampsia.
23
Neonatal mortality 0.6-1.2%.
24
Long-term neurodevelopmental issues in 10-15% offspring.
25
Maternal mortality ratio from preeclampsia/eclampsia: 16% of direct causes.
26
In high-resource settings, maternal mortality <0.1%.
Interpretation

Outcomes Interpretation

Preeclampsia is a masterclass in long-term collateral damage, leaving behind a sobering legacy of elevated risks for both mother and child that echo far beyond the final push of labor.

05 · Category

Risk Factors25 stats

01
Maternal age >35 years increases risk by 1.5-2 fold.
02
Nulliparity raises preeclampsia risk 2-3 times.
03
Obesity (BMI ≥30) triples preeclampsia risk.
04
Chronic hypertension multiplies risk by 5-10 times.
05
Diabetes (pregestational) increases risk 4-fold.
06
Multiple gestation doubles to quadruples risk.
07
Family history of preeclampsia raises risk 2-4 times.
08
Black race/ethnicity has 1.5-2 times higher risk.
09
Previous preeclampsia history: 15-20% recurrence risk.
10
Autoimmune diseases like lupus raise risk 5-10 times.
11
Smoking decreases preeclampsia risk by 20-30%.
12
Partner with previous preeclamptic pregnancy: 2-fold risk increase.
13
Short interpregnancy interval (<2 years) increases risk 1.5 times.
14
Assisted reproductive technology (ART) pregnancies: 1.75 relative risk.
15
Gestational diabetes adds 1.5-2 fold risk.
16
Renal disease history: 20-30% preeclampsia incidence.
17
Thrombophilias (e.g., factor V Leiden) increase risk 1.5-2 times.
18
High altitude living (>2500m) doubles risk.
19
Low socioeconomic status correlates with 1.5 times higher risk.
20
BMI 25-29.9: 1.7 relative risk for preeclampsia.
21
BMI ≥35: 4.2 relative risk.
22
Antiphospholipid syndrome: 40-50% risk.
23
Prior fetal growth restriction: 2-3 fold risk.
24
Hydrops fetalis history increases risk.
25
Interleukin-6 gene polymorphism raises risk 2-fold.
Interpretation

Risk Factors Interpretation

While motherhood is a masterpiece of biology, the statistics suggest it's best started on a fresh, healthy canvas free of certain prior sketches, invasive editors, or a high-stakes plot inherited from your family or partner's backstory.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Christopher Morgan. (2026, February 13). Preeclampsia Statistics. Gitnux. https://gitnux.org/preeclampsia-statistics
MLA
Christopher Morgan. "Preeclampsia Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/preeclampsia-statistics.
Chicago
Christopher Morgan. 2026. "Preeclampsia Statistics." Gitnux. https://gitnux.org/preeclampsia-statistics.

Sources & references

9 datasets cited across this report · attribution is report-level